StellarOne Corp’s Novo Nordisk NVO Stock Holding History

StellarOne Corp’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	$7K	Hold	400	–	–	0.01%	194
2013 Q2	$6K	Buy	+400	New	+$6.66K	﹤0.01%	202

Other funds holding NVO

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sarofim Fayez Houston, Texas $20.5B AUM

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

TIM

Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

StellarOne Corp's NVO Position: Q3 2013 in Review

StellarOne Corp held its Novo Nordisk (NVO) position steady in Q3 2013 at 400 shares worth $7K. The position accounts for 0.01% of the portfolio, ranked #194.

StellarOne Corp first reported a position in NVO in Q2 2013 and has held it in 2 quarters since. 425 funds tracked by Wall St. Rank hold NVO as of Q3 2013.

StellarOne Corp held 400 shares of Novo Nordisk worth $7K as of Q3 2013.
StellarOne Corp left its Novo Nordisk share count unchanged in Q3 2013.
Novo Nordisk made up 0.01% of StellarOne Corp's portfolio in Q3 2013, its #194 holding.
StellarOne Corp first reported a position in Novo Nordisk in Q2 2013 and has held it in 2 quarters since.
425 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2013.

Based on StellarOne Corp's 13F filing for Q3 2013, filed 12 Nov 2013.